概述

  • 产品名称DAMGO
  • 描述
    Potent and selective μ opioid receptor agonist
  • 生物学描述Potent and selective μ opioid receptor agonist (Ki values are 2.0, >1000 and >1000 nM for opioid receptor subtypes μ, κ and δ, respectively). Partial central activity following systemic administration. Antinociceptive.
  • 纯度> 95%

性能

    DAMGO (ab120674)参考文献

    This product has been referenced in:
    • Lowery JJ  et al. Glycosylation improves the central effects of DAMGO. Chem Biol Drug Des 69:41-7 (2007). Read more (PubMed: 17313456) »
    • Shin MS & Helmstetter FJ Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala. Brain Res 1064:56-65 (2005). Read more (PubMed: 16289487) »
    • Raynor K  et al. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45:330-4 (1994). Read more (PubMed: 8114680) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120674.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"